GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC
BackgroundTNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted drugs, it is crucial to identify critical factors...
Main Authors: | Huaying Xie, Tingting Yan, Xinxin Lu, Yueyao Du, Shuguang Xu, Yu Kong, Liangjie Yu, Jian Sun, Liheng Zhou, Jun Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033367/full |
Similar Items
-
Novel GLDC variants causing nonketotic hyperglycinemia in Chinese patients
by: Zhao Xiangyue, et al.
Published: (2022-10-01) -
Identification and characterization of GLDC as host susceptibility gene to severe influenza
by: Jie Zhou, et al.
Published: (2019-01-01) -
<i>gldc</i> Is Essential for Renal Progenitor Patterning during Kidney Development
by: Nicole E. Weaver, et al.
Published: (2022-12-01) -
A novel compound heterozygous variant identified in GLDC gene in a Chinese family with non-ketotic hyperglycinemia
by: Yiming Lin, et al.
Published: (2018-01-01) -
Novel homozygous GLDC variant causing late-onset glycine encephalopathy: A case report and updated review of the literature
by: Minh-Tuan Huynh, et al.
Published: (2023-03-01)